272
Views
0
CrossRef citations to date
0
Altmetric
Review

Current insights into skin banking: storage, preservation and clinical importance of skin allografts

, , , , , , & show all
Pages 41-56 | Published online: 18 Jul 2017

References

  • Webster JP. Refrigerated skin grafts. Ann Surg. 1944;120(4):431–439.
  • Matthews DN. Storage of skin for autogenous grafts. Lancet. 1945;2:775–758.
  • Barker CF, Markmann JF. Historical overview of transplantation. Cold Spring Harb Perspect Med. 2013;3(4):a014977.
  • McCauley RL. The skin bank. Total burn care. 1st ed. Philadelphia, PA: Saunders; 1996:159–163.
  • Mericka P. Brief history of the tissue bank, Charles University Hospital, Hradec Kralove, Czech Republic. Cell Tissue Bank. 2000;1(1):17–25.
  • Freedlander E, Boyce S, Ghosh M, Ralston DR, MacNeil S. Skin banking in the UK: the need for proper organization. Burns. 1998;24(1):19–24.
  • Pianigiani E, Ierardi F, Cherubini Di Simplicio F, Andreassi A. Skin bank organization. Clin Dermatol. 2005;23(4):353–356.
  • Matesanz R, Mirand B, Felipe C, Fernandez M, Naya MT. The national transplant organization – donation evolution and transplant activity in Spain. Ann Transplant. 1996;1(3):45–56.
  • Allorto NL, Rogers AD, Rode H. “Getting under our skin”: introducing allograft skin to burn surgery in South Africa. S Afr Med J. 2016;106(9):865–866.
  • Gore MA, De AS. Deceased donor skin allograft banking: response and utilization. Indian J Plast Surg. 2010;43(Suppl):S114–S120.
  • Martínez-Floresa F, Chacón-Gómeza M, Madinaveitia-Villanueva JA, Barrera-Lopez A, Aguirre-Cruz L, Querevalu-Murillo W. [The clinical use of cryopreserved human skin allografts for transplantation.] Cir Cir. 2015;83(6):485–491. Spanish.
  • Saffle JR. Closure of the excised burn wound: temporary skin substitutes. Clin Plast Surg. 2009;36(4):627–641.
  • Leon-Villapalos J, Eldardiri M, Dziewulski P. The use of human deceased donor skin allografts in burn care. Cell Tissue Bank. 2010;11(1):99–104.
  • Gaucher S, Jarraya M. Cryopreserved human skin allografts: efficacy and viability. Burns. 2014;40(3):526–527.
  • Kagan RJ, Robb EC, Plessinger RT. Human skin banking. Clin Lab Med. 2005;25(3):587–605.
  • Kearney JN. Guidelines on processing and clinical use of skin allografts. Clin Dermatol. 2005;23(4):357–364.
  • Gaucher S, Elie C, Verola O, Jarraya M. Viability of cryopreserved human skin allografts: effects of transport media and cryoprotectants. Cell Tissue Bank. 2012;13(1):147–155.
  • Official Journal of the European Union. Directive 2004/23/EC of the European Parliament and Council on quality and safety standards for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Official Journal of the European Union; 2004. Available from: http://eur-lex.europa.eu/Lex-UriServ/LexUriServ.do?uri=OJ:L:2004:102:0048:0058:en:PDF. Accessed June 5, 2017.
  • Commission Directive 2006/17/EC implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells. Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32006L0017. Accessed June 5, 2017.
  • Commission Directive 2006/86/EC implementing Directive 2004/23/EC of the European Parliament and of the Council as regards traceability requirements, notification of serious adverse reactions and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells. Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32006L0086. Accessed June 5, 2017.
  • European commission [homepage on the Internet]. EudraLex – Volume 4 – Good Manufacturing Practice (GMP) guidelines; 2010 [updated December, 2010]. Available at: https://ec.europa.eu/health/documents/eudralex/vol-4_en. Accessed June 29, 2017.
  • Ireland L, McKelvie H. Tissue banking in Australia. Cell Tissue Bank. 2003;4(2–4):151–156.
  • Linee guida per il prelievo, la processazione e la distribuzione dei tessuti a scopo di trapianto – Centro Nazionale per i Trapianti (CNT); 2015. Available from: http://www.trapianti.salute.gov.it. Accessed January 2, 2017.
  • European Directorate for the Quality of medicines & Health Care (EDQM). Guide to the quality and safety of tissues and cells for human application. France; 2015. Available from https://www.edqm.eu/sites/default/files/foreword_list_of_contents_tissues_cell_guide_2nd_edition_2015.pdf. Accessed June 5, 2017.
  • Vicentino M, Rodriguez G, Saldias M, Alvarez I. Guidelines to implement quality management systems in microbiology laboratories for tissue banking. Transplant Proc. 2009;41(8):3481–3484.
  • Kearney JN. Quality issues in skin banking: a review. Burns. 1998;24(4):299–305.
  • Code of Federal Regulations. Title 21, Chapter 1, Subchapter L, Volume 8 [Revised as of April 1, 2016]. Part 1271: Human cells, tissues and cellular and tissue-based products. Subpart D: Current Good Tissue Practice. Sec. 1271.215: Recovery
  • Pianigiani E, Ierardi F, Fimiani M. Importance of good manufacturing practices in microbiological monitoring in processing human tissues for transplant. Cell Tissue Bank. 2013;14(4):601–607.
  • Verbeken G, Verween G, De Vos D, et al. Glycerol treatment as recovery procedure for cryopreserved human skin allografts positive for bacteria and fungi. Cell Tissue Bank. 2012;13(1):1–7.
  • Pianigiani E, Ierardi F, Cuciti C, Brignali S, Oggioni M, Fimiani M. Processing efficacy in relation to microbial contamination of skin allografts from 723 donors. Burns. 2010;36(3):347–351.
  • Pianigiani E, Risulo M, Ierardi F, et al. Prevalence of skin allograft discards as a result of serological and molecular microbiological screening in a regional skin bank in Italy. Burns. 2006;32(3):348–351.
  • Pirnay JP, Verween G, Pascual B, et al. Evaluation of a microbiological screening and acceptance procedure for cryopreserved skin allografts based on 14-day cultures. Cell Tissue Bank. 2012;13(2):287–295.
  • Castagnoli C, Alotto D, Cambieri I, et al. Evaluation of donor skin viability: fresh and cryopreserved skin using tetrazolium salt assay. Burns. 2003;29(8):759–767.
  • Franchini M, Zanini D, Bosinelli A, et al. Evaluation of cryopreserved donor skin viability: the experience of the regional tissue bank of Verona. Blood Transfus. 2009;7(2):100–105.
  • Kua EH, Goh CQ, Ting Y, Chua A, Song C. Comparing the use of glycerol preserved and cryopreserved allogenic skin for the treatment of severe burns: differences in clinical outcomes and in vitro tissue viability. Cell Tissue Bank. 2012;13(2):269–279.
  • Pianigiani E, Tognetti L, Ierardi F, et al. Assessment of cryopreserved donor skin viability: the experience of the regional tissue bank of Siena. Cell Tissue Bank. 2016;17(2):241–253.
  • Hermans MHE. Preservation methods of allografts and their (lack of) influence on clinical results in partial thickness burns. Burns. 2011;37(5):873–881.
  • Cleland H, Wasiak J, Dobson H, et al. Clinical application and viability of cryopreserved cadaveric skin allografts in severe burns: a retrospective analysis. Burns. 2014;40(1):61–66.
  • Van Baare J, Cameron PU, Vardaxis N, et al. Comparison of glycerol preservation with cryopreservation methods on HIV-1 inactivation. J Burn Care Rehabil. 1998;19(6):494–500.
  • Blondet R, Gibert-Thevenin MA, Pierre C, Ehrsam A. Skin preservation by programmed freezing. Br J Plast Surg. 1982;35:530–536.
  • Livesey SA, Herndon DN, Hollyoak MA, Atkinson YH, Nag A. Transplanted acellular allograft dermal matrix. Transplantation. 1995;60(1):1–9.
  • Johnston C, Callum J, Mohr J, et al. Disinfection of human skin allografts in tissue banking: a systematic review report. Cell Tissue Bank. 2016;17(4):585–592.
  • Ferrando PM, Balmativola B, Cambieri I, et al. Glycerolized reticular dermis as a new human acellular dermal matrix: an exploratory study. PloS One. 2016;11(2):e0149124.
  • May SR, Roberts DP. Development of a passive device for freezing large amounts of transplantable skin at one time in a −70°C mechanical refrigerator. Cryobiology. 1988;25(3):186–196.
  • Bravo D, Rigley TH, Gibran N, Strong DM, Newman-Gage H. Effect of storage and preservation methods on viability in transplantable human skin allografts. Burns. 2000;26(4):367–378.
  • Schiozer WA, Gemperli R, Mu¨hlbauer W, et al. An outcome analysis and long-term viability of cryopreserved cultured epidermal allografts. Assessment of the conservation of transplantable human skin allografts. Acta Cir Bras. 2013;28(12):824–832.
  • Li Z, Overend C, Maitz P, Kennedy P. Quality evaluation of meshed split-thickness skin grafts stored at 4°C in isotonic solutions and nutrient media by cell cultures. Burns. 2012;38(6):899–907.
  • Udoh Y, Yanaga H, Tai Y, et al. Long-term viability of cryopreserved cultured epithelial grafts. Burns. 2000:26(6):535–542.
  • Robb EC, Bechmann N, Plessinger RT, et al. Storage media and temperature maintain normal anatomy of cadaveric human skin for transplantation to full-thickness skin wounds. J Burn Care Rehabil. 2001;22(6):393–396.
  • Walcerz DB, Karow AM. Cryopreservation of cells for tissue engineering. Tissue Eng. 1996; 2(2):85–96.
  • De Luca M, Albanese E, Bondanza S, et al. Multicentre experience in the treatment of burns with autologous and allogenic cultured epithelium, fresh or preserved in a frozen state. Burns. 1989;15(5):303–309.
  • Teepe RGC, Koebrugge EJ, Ponec M, Vermeer BJ. Fresh versus cryopreserved cultured allografts for the treatment of chronic skin ulcers. British Journal of Dermatology, 1990;122:81–89.
  • Mackie DP. The Euro Skin Bank: development and application of glycerol-preserved allografts. J Burn Care Rehabil, 1997;18(1):S7–S9.
  • Mackie D. Postal survey on the use of glycerol-preserved allografts in clinical practice. Burns. 2002;28(Suppl. 1):S40–S44.
  • Blome-Eberwein S, Jester A, Kuentscher M, Raff T, Germann G, Pelzer M. Clinical practice of glycerol-preserved allograft skin coverage. Burns. 2002;28(Suppl. 1):S10–S12.
  • Wood JM, Soldin M, Shaw TJ, Szarko M. The biomechanical and histological sequelae of common skin banking methods. J Biomech. 2014;47(5):1215–1219.
  • Schirmbeck T. Biomechanical and histological evaluation of glycerol-preserved human sclerae. Arq Bras Oftalmol. 2007;70(6):988–990.
  • Saegeman VS, Ectors NL, Lismont D, Verduyckt B, Verhaegen J. Short- and long-term bacterial inhibiting effect of high concentrations of glycerol used in the preservation of skin allografts. Burns. 2008;34(2):205–211.
  • Hamilton KT, Herson MR. Skin bank development and critical incident response. Cell Tissue Bank. 2011;12(2):147–151.
  • Khoo TL, Halim AS, Mat Saad AZ, Dorai AA. The application of glycerol-preserved skin allograft in the treatment of burn injuries: An analysis based on indications. Burns. 2010;36(8):97–904.
  • Vloemans AF, Schreinemachers MC, Middelkoop E, Kreis RW. The use of glycerol-preserved allografts in the Beverwijk Burn Centre: a retrospective study. Burns, 2002;28(Suppl. 1):S2–S9.
  • Singh R, Singh D, Singh A. Radiation sterilization of tissue allografts: A review. World J Radiol. 2016;8(4):355–369.
  • Rooney P, Eagle M, Hogg P, et al. Sterilisation of skin allograft with gamma irradiation. Burns. 2008;34(5):664–673.
  • Dearth CL, Keane TJ, Carruthers CA, et al. The effect of terminal sterilization on the material properties and in vivo remodeling of a porcine dermal biologic scaffold. Acta Biomater. 2016;33:78–87.
  • Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissues and organs. Biomaterials. 2006;27(19):3675–3683.
  • Pianigiani E, Tognetti L, Ierardi F, et al. Il derma acellulare liofilizzato. Hi-Tech Dermo. 2016;3:17–20.
  • Hauben, DJ, Baruchin A, Mahler A. On the history of the free skin graft. Ann Plast Surg. 1982;9(3):242–245.
  • Eurocode.org [database on the Internet]. Germany: Eurocode IBLS; 2013. Available from: http://www.eurocode.org/tables/products/index.html. Section:products code catalogue/tissue/751001/F:tissue preservation. Accessed June 5, 2017.
  • Blair R. Guide and bibliography for research into the skin homograft problem. Plast Reconstr Surg (1946). 1951;7(3):169–201.
  • Gibson T, Medawar PB. The fate of skin homografts in man. J Anat. 1943;77(Pt 4):299–310.
  • Cuono CB, Langdon R, Birchall N, et al. Composite autologous-allogeneic skin replacement: development and clinical application. Plast Reconstr Surg. 1987;80(4):626–637.
  • Alexander JW, MacMillan BG, Law E, et al. Treatment of severe burns with widely meshed skin autograft and widely meshed skin allograft overlay. J Trauma. 1981;21(6):433–438.
  • Debels H, Hamdi M, Abberton K, Morrison W. Dermal matrices and bioengineered skin substitutes: a critical review of current options. Plast Reconstr Surg Glob Open. 2015;3(1):e284.
  • Fimiani M, Pianigiani E, Di Simplicio FC, et al. Other uses of homologous skin grafts and skin bank bioproducts. Clin Dermatol. 2005;23(4):396–402.
  • Human tissue intended for transplantation–FDA. Interim rule; opportunity for public comment. Fed Regist. 1993;58(238):65514–65552.
  • Dickinson LE, Gerecht S. Engineered biopolymeric scaffolds for chronic wound healing. Front Physiol. 2016;7:341.
  • Strong DM. The US Navy Tissue Bank: 50 years on the cutting edge. Cell and Tissue Banking. 2000;1(1):9–16.